12400 RACE TRACK ROAD, TAMPA, FL
SRX Global Inc. Enters Stock Purchase Agreement with CERo Therapeutics
Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim
SRX Global Inc. Enters $2.825 Million Securities Purchase Agreement
Acquires Senior Secured Debt in an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers
SRX Global Inc. Enters $2.86M Securities Purchase Agreement
Announces Fiscal Third Quarter 2026 Financial Results
Amended material disclosure
Unregistered Sales of Equity Securities
Q2
Q1
Q4
FY 2024
Notice of Late Filing for Quarterly Report
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
S-4/A
Definitive Information Statement
Preliminary Information Statement
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Definitive Revised Information Statement
SEC Staff Action Letter
Submission Upload
PREM14A
Correspondence